Enzypep Overview

  • Founded
  • 2012
  • Status
  • Out of Business
  • Employees
  • 6
  • Latest Deal Type
  • Out of Business

Enzypep General Information


Developer of peptide ligation technology designed to offer the synthesis of oligopeptides. develops green, sustainable and cost-effective routes to synthesize pharmaceutical peptides and bioconjugates using its proprietary CEPS (Chemo Enzymatic Peptide Synthesis) and PECON (Protein Enzymatic CONjugation) toolbox, enabling companies to create pharmaceutical products with much higher purity, at a much lower cost and in a sustainable, environmentally-friendly manner.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Other Industries
Drug Discovery
Primary Office
  • Brightlands Campus
  • Building 93. Room 093.3.220, Urmonderbaan 22
  • 6167 RD Geleen
  • Netherlands
+31 046 000 0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Enzypep Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Out of Business 01-Jan-2019 00.000 Completed Out of Business
2. Early Stage VC 01-Jan-2015 00.000 00.000 Completed Startup
1. Early Stage VC 01-Jun-2012 Completed Startup
To view Enzypep’s complete valuation and funding history, request access »

Enzypep Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial